ModerateHMG-CoA reductase inhibitors (statins)×Antimetabolites, folic acid analogues
Updated · Methodology
Mechanism
Atorvastatin blocks OATP1B1 – the hepatic methotrexate uptake route. Methotrexate plasma levels may rise. The effect is clinically significant at high oncologic methotrexate doses.
Symptoms
Stomatitis, diarrhoea, falling leukocyte and platelet counts. In patients with borderline renal function: severe toxicity risk.
Management
At low rheumatological methotrexate doses (5–25 mg/week), the combination is acceptable without adjustment. At high oncologic doses, temporarily withhold atorvastatin for 24–48 hours after methotrexate administration.
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- FDA: Methotrexate Sodium Tablets prescribing information (2016)– ; DailyMed setid 8f1260de-b60c-4f0e-8af6-0e957b0a281b